SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-07-076196
Filing Date
2007-10-23
Accepted
2007-10-22 19:23:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 425 a07-27173_18k.htm 425 48773
2 EX-2.1 a07-27173_1ex2d1.htm EX-2.1 710931
3 EX-10.2 a07-27173_1ex10d2.htm EX-10.2 25631
4 EX-10.3 a07-27173_1ex10d3.htm EX-10.3 132598
5 EX-99.1 a07-27173_1ex99d1.htm EX-99.1 25478
6 GRAPHIC g271731mni001.jpg GRAPHIC 9552
  Complete submission text file 0001104659-07-076196.txt   958825
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filed by) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-15006 | Film No.: 071184056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances